Supriya Lifescience Limited Market Cap ($756.89 Million)
Market Cap & Net Worth: Supriya Lifescience Limited (SUPRIYA)
Supriya Lifescience Limited market cap. Supriya Lifescience Limited (NSE:SUPRIYA) has a market capitalization of $756.89 Million (Rs69.99 Billion) as of November 6, 2026. Listed on the NSE stock exchange, this India-based company holds position #9876 globally and #498 in its home market, demonstrating a 0.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Supriya Lifescience Limited's stock price Rs869.60 by its total outstanding shares 80482800 (80.48 Million). Also see Supriya Lifescience Limited (SUPRIYA) cash conversion ratio for how efficiently the company converts equity into cash flow.
Supriya Lifescience Limited Market Cap History (2021–2026)
Supriya Lifescience Limited market cap history from 2021 to 2026. Data shows growth from $418.88 Million to $756.89 Million (18.02% CAGR). Check Supriya Lifescience Limited share price for real-time trading data and today's change.
Index Memberships
Supriya Lifescience Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$146.42 Billion | 0.52% | #73 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.19 Trillion | 0.02% | #398 of 750 |
Weight: Supriya Lifescience Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Supriya Lifescience Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Supriya Lifescience Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Supriya Lifescience Limited net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.09x
Supriya Lifescience Limited's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.35x
Supriya Lifescience Limited's market cap is 0.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $418.88 Million | $3.85 Billion | $1.24 Billion | 0.11x | 0.34x |
| 2022 | $203.90 Million | $5.19 Billion | $1.52 Billion | 0.04x | 0.13x |
| 2023 | $273.60 Million | $4.51 Billion | $898.57 Million | 0.06x | 0.30x |
| 2024 | $643.92 Million | $5.70 Billion | $1.19 Billion | 0.11x | 0.54x |
| 2025 | $654.10 Million | $6.96 Billion | $1.88 Billion | 0.09x | 0.35x |
Competitor Companies of SUPRIYA by Market Capitalization
Companies near Supriya Lifescience Limited in the global market cap rankings as of November 6, 2026. Also see SUPRIYA current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Supriya Lifescience Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #176 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #364 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #405 globally with a market cap of $69.48 Billion USD ( AU$98.19 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #499 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #176 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $542.50 |
| #364 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $902.90 |
| #405 | CSL Ltd | AU:CSL | $69.48 Billion | AU$202.40 |
| #499 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $241.46 |
Market Capitalization of Supriya Lifescience Limited (2021–2026)
Market capitalization of Supriya Lifescience Limited from 2021 to today. Between 2021 and today, Supriya Lifescience Limited's market cap moved from $418.88 Million to $ 756.89 Million, with a yearly change of 18.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs756.89 Million | +15.72% |
| 2025 | Rs654.10 Million | +1.58% |
| 2024 | Rs643.92 Million | +135.35% |
| 2023 | Rs273.60 Million | +34.18% |
| 2022 | Rs203.90 Million | -51.32% |
| 2021 | Rs418.88 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Supriya Lifescience Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $756.89 Million USD |
| MoneyControl | $756.89 Million USD |
| MarketWatch | $756.89 Million USD |
| marketcap.company | $756.89 Million USD |
| Reuters | $756.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Supriya Lifescience Limited
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary… Read more